NCT04083157View on ClinicalTrials.gov

Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2021

Conditions
Inflammatory Bowel DiseasesHepatitis B
Interventions
BIOLOGICAL

Intradermal hepatitis B vaccine with imiquimod

Intradermal hepatitis B vaccine with topical imiquimod pretreatment

BIOLOGICAL

Intramuscular hepatitis B vaccine with aqueous cream

Intramuscular hepatitis B vaccine with topical aqueous cream pretreatment

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT04083157 - Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients | Biotech Hunter | Biotech Hunter